Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of National MELD ≥ 30 Priority Allocation System on Dropout and Post-Transplant Survival Rates in Italy: A Retrospective Competing-Risk Analysis

NCT04530240 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT04530240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of National MELD ≥ 30 Priority Allocation System on Dropout and Post-Transplant Survival Rates in Italy: A Retrospective Competing-Risk Analysis
Lead sponsor
University of Bologna
Phase
Observational
Overall status
Completed
Start date
August 1, 2010
Completion date
December 31, 2019
Enrollment
4,238 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, liver transplant disorder